Immunodiagnostic Systems Holdings PLC (LON:IDH) insider Paul James Martin bought 2,000 shares of the firm’s stock in a transaction dated Wednesday, March 21st. The shares were acquired at an average cost of GBX 228 ($3.15) per share, with a total value of £4,560 ($6,300.08).

Shares of Immunodiagnostic Systems stock opened at GBX 230 ($3.18) on Thursday. Immunodiagnostic Systems Holdings PLC has a 12-month low of GBX 210 ($2.90) and a 12-month high of GBX 345 ($4.77). The stock has a market capitalization of $73.74 and a price-to-earnings ratio of 2,300.00.

COPYRIGHT VIOLATION NOTICE: “Immunodiagnostic Systems Holdings PLC (IDH) Insider Paul James Martin Acquires 2,000 Shares of Stock” was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this story can be viewed at https://www.watchlistnews.com/immunodiagnostic-systems-holdings-plc-idh-insider-paul-james-martin-acquires-2000-shares-of-stock/1954741.html.

About Immunodiagnostic Systems

Immunodiagnostic Systems Holdings PLC is a specialist in vitro diagnostic solution provider to the clinical laboratory market. The Company develops, manufactures and markets immunoassays and automated immunoanalyser technologies. It operates through three business segments: Automated IVD, Manual IVD, and Licensing & Technology.

Receive News & Ratings for Immunodiagnostic Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immunodiagnostic Systems and related companies with MarketBeat.com's FREE daily email newsletter.